Towards antivirals against chikungunya virus, Antiviral Research, vol.121, pp.59-68, 2015. ,
DOI : 10.1016/j.antiviral.2015.06.017
Chikungunya virus infections: time to act, time to treat, Current Opinion in Virology, vol.24, pp.25-30, 2017. ,
DOI : 10.1016/j.coviro.2017.03.016
Sequence analysis reveals a conserved extension in the capping enzyme of the alphavirus supergroup, and a homologous domain in nodaviruses, Biology Direct, vol.299, issue.5881, p.16, 2015. ,
DOI : 10.1038/299371a0
Suramin inhibits chikungunya virus replication through multiple mechanisms, Antiviral Research, vol.121, pp.39-46, 2015. ,
DOI : 10.1016/j.antiviral.2015.06.013
Chikungunya: a re-emerging virus, The Lancet, vol.379, issue.9816, pp.662-671, 2012. ,
DOI : 10.1016/S0140-6736(11)60281-X
Chikungunya virus and arthritic disease, The Lancet Infectious Diseases, vol.14, issue.9, pp.789-790, 2014. ,
DOI : 10.1016/S1473-3099(14)70869-2
Regioselective 1,3-Dipolar Cycloaddition Reaction of Azides with Alkoxy Alkynyl Fischer Carbene Complexes, Organometallics, vol.29, issue.23, pp.6619-6622, 2010. ,
DOI : 10.1021/om1009523
]quinoline Derivatives as Selective and Orally Active Compounds against Non-Small-Cell Lung Cancers, Journal of Medicinal Chemistry, vol.54, issue.13, 2011. ,
DOI : 10.1021/jm200046z
]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses, Journal of Medicinal Chemistry, vol.58, issue.23, pp.9196-9213, 2015. ,
DOI : 10.1021/acs.jmedchem.5b01047
Chikungunya virus pathogenesis: From bedside to bench, Antiviral Research, vol.121, pp.120-131, 2015. ,
DOI : 10.1016/j.antiviral.2015.07.002
URL : https://hal.archives-ouvertes.fr/pasteur-01204785
Chikungunya virus: an update on antiviral development and challenges, Drug Discovery Today, vol.18, issue.19-20, pp.969-983, 2013. ,
DOI : 10.1016/j.drudis.2013.05.002
Suramin treatment reduces chikungunya pathogenesis in mice, Antiviral Research, vol.134, pp.89-96, 2016. ,
DOI : 10.1016/j.antiviral.2016.07.025
URL : https://doi.org/10.1016/j.antiviral.2016.07.025
Antiviral activity of selected flavonoids against Chikungunya virus, Antiviral Research, vol.133, pp.50-61, 2016. ,
DOI : 10.1016/j.antiviral.2016.07.009
ABSTRACT, Journal of Virology, vol.89, issue.16, pp.8292-8303 ,
DOI : 10.1128/JVI.00599-15
URL : https://hal.archives-ouvertes.fr/hal-00232969
Molecular epidemiology, evolution and phylogeny of Chikungunya virus: An updating review, Infection, Genetics and Evolution, vol.41, pp.270-278, 2016. ,
DOI : 10.1016/j.meegid.2016.04.006
Inhibition of Chikungunya Virus Replication by 1-[(2-Methylbenzimidazol-1-yl) Methyl]-2-Oxo-Indolin-3-ylidene] Amino] Thiourea(MBZM-N-IBT), IBT). Sci. Rep. 6, 2016. ,
DOI : 10.1128/AAC.49.11.4437-4442.2005
URL : http://www.nature.com/articles/srep20122.pdf
Synthesis of fused pyrimidinones by reaction of aminoarene-carboxamide with esters; Preparation, pyrimidinones, and quinazolones, pp.3-5, 1996. ,
Indirubin Core Structure of Glycogen Synthase Kinase-3 Inhibitors as Novel Chemotype for Intervention with 5-Lipoxygenase, Journal of Medicinal Chemistry, vol.57, issue.9, pp.3715-3723, 2014. ,
DOI : 10.1021/jm401740w
Risks to the Americas associated with the continued expansion of chikungunya virus, Journal of General Virology, vol.123, issue.1, pp.1-5, 2015. ,
DOI : 10.1016/j.actatropica.2012.03.004
Chikungunya Virus: Emerging Targets and New Opportunities for Medicinal Chemistry, Journal of Medicinal Chemistry, vol.57, issue.4, 2013. ,
DOI : 10.1021/jm400460d
Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk, Journal of Clinical Virology, vol.64, pp.144-152, 2015. ,
DOI : 10.1016/j.jcv.2014.08.032
Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy, Antiviral Research, vol.99, issue.3, pp.345-370, 2013. ,
DOI : 10.1016/j.antiviral.2013.06.009
Chikungunya: A Potentially Emerging Epidemic?, PLoS Neglected Tropical Diseases, vol.28, issue.4, p.623, 2010. ,
DOI : 10.1371/journal.pntd.0000623.t002
URL : https://doi.org/10.1371/journal.pntd.0000623
ABSTRACT, Journal of Virology, vol.90, issue.21, pp.9743-9757, 2016. ,
DOI : 10.1128/JVI.01382-16
Soluble 3???,6-Substituted Indirubins with Enhanced Selectivity toward Glycogen Synthase Kinase -3 Alter Circadian Period, Journal of Medicinal Chemistry, vol.51, issue.20, pp.6421-6431, 2008. ,
DOI : 10.1021/jm800648y
URL : http://europepmc.org/articles/pmc2717725?pdf=render
Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission, Antiviral Research, vol.135, pp.81-90, 2016. ,
DOI : 10.1016/j.antiviral.2016.10.003
Chikungunya: Evolutionary history and recent epidemic spread, Antiviral Research, vol.120, pp.32-39, 2015. ,
DOI : 10.1016/j.antiviral.2015.04.016